The legacy of Viagra, and its developer copyright, presents a complex case study for investors. Initially a blockbuster drug, generating billions in revenue , its patent expiration created a wave of knock-off medications, significantly impacting its dominance. While some businesses may try to capitalize on similar conditions , the present landscape